Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-075472
Filing Date
2015-10-14
Accepted
2015-10-14 17:59:19
Documents
1
Period of Report
2015-10-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3961
  Complete submission text file 0001209191-15-075472.txt   5370
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Issuer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DYNAVAX TECHNOLOGIES CORPORATION 2929 SEVENTH STREET, SUITE 100 BERKELEY CA 94710
Business Address
Phillips Peggy V (Reporting) CIK: 0001373026 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34207 | Film No.: 151158860